Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis-Reference-Cited by-同舟云学术

Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis

Published:2023-04 Issue: Volume:Volume 15 Page:217-230
ISSN:1179-1608
Container-title:Nature and Science of Sleep
language:en
Short-container-title:NSS

Author:

Zhan Shuqin,Ye Hui,Li Ning,Zhang Yimeng,Cheng Yueyang,Wang Yuanqing,Hu Shimin^ORCID,Hou Yue

Publisher

Informa UK Limited

Subject

Behavioral Neuroscience,Applied Psychology

Reference79 articles.

1. Prevalence of narcolepsy symptomatology and diagnosis in the European general population

2. Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning

3. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel biomarkers derived from the Maintenance of Wakefulness Test as predictors of sleepiness and response to treatment;SLEEP;2024-07-02

2. Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data;Advances in Therapy;2024-05-22

3. Opioid, cannabinoid, cocaine, and methamphetamine epidemics: History, risk factors associated with them, and characteristics of drug action;Psychopharmacology & biological narcology;2023-12-15

4. Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea;CNS Drugs;2023-10-17

5. Pharmacological options for narcolepsy: are they the way forward?;Expert Review of Neurotherapeutics;2023-08-29